![]() Gynecologic Tumors: From Lymph Node Dissection to Sentinel Lymph Node MappingĪmong the top 10 malignancies in women, ovarian cancer ranks 5th, with an estimated 12,810 new deaths, and uterine corpus cancer ranks 6th, with an estimated 12,550 new deaths ( 1). In this review, we summarize different dyes and injection methods and discuss the indications of application and the clinical trials of SLN mapping in gynecological malignant tumors, aiming to provide a reference for the rational application of sentinel techniques in gynecology malignant tumors before relevant guidelines are updated. The National Comprehensive Cancer Network (NCCN) guidelines provide an excellent introduction to the indications and methods of SLN techniques in vulvar, cervical, and endometrial cancers, but they provide little explanation about some specific issues. In the evaluation of the status of lymph node metastases in gynecological malignancies, it has received increasingly more attention due to its minor invasiveness, few complications, and high diagnosis rate. It is widely used in a variety of tumor surgeries for its high sensitivity and high negative predictive value. SLN mapping refers to intraoperative localization and biopsy of SLNs with specific tracers to assess lymph node metastases. The sentinel lymph nodes (SLNs) is a group of lymph nodes initially involved in the metastatic spread of cancer cells.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |